BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34103027)

  • 1. Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma.
    Peng G; Chai H; Ji W; Lu Y; Wu S; Zhao H; Li P; Hu Q
    BMC Med Genomics; 2021 Jun; 14(1):150. PubMed ID: 34103027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
    Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
    Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
    Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
    Rennstam K; Ahlstedt-Soini M; Baldetorp B; Bendahl PO; Borg A; Karhu R; Tanner M; Tirkkonen M; Isola J
    Cancer Res; 2003 Dec; 63(24):8861-8. PubMed ID: 14695203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.
    Guo X; Yanna ; Ma X; An J; Shang Y; Huang Q; Yang H; Chen Z; Xing J
    PLoS One; 2011; 6(12):e28404. PubMed ID: 22174799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study.
    Liu YJ; Zhou Y; Yeh MM
    Mol Cytogenet; 2014; 7(1):81. PubMed ID: 25469175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
    Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ
    Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
    Zhao K; Zhao Y; Zhu JY; Dong H; Cong WM; Yu Y; Wang H; Zhu ZZ; Xu Q
    Curr Med Sci; 2018 Aug; 38(4):590-596. PubMed ID: 30128866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
    Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
    Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
    Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
    Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.
    Kuglik P; Smetana J; Vallova V; Moukova L; Kasikova K; Cvanova M; Brozova L
    Int J Clin Exp Pathol; 2014; 7(8):5071-82. PubMed ID: 25197380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of copy number alterations in a mouse model of fibrosis-associated hepatocellular carcinoma reveals concordance with human disease.
    Chappell G; Silva GO; Uehara T; Pogribny IP; Rusyn I
    Cancer Med; 2016 Mar; 5(3):574-85. PubMed ID: 26778414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.
    Zhu ZZ; Bao LL; Zhao K; Xu Q; Zhu JY; Zhu KX; Wen BJ; Ye YQ; Wan XX; Wang LL; He SQ; Cong WM
    Curr Med Sci; 2019 Oct; 39(5):759-765. PubMed ID: 31612394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenetic tree modeling of human hepatocarcinogenesis.
    Longerich T; Mueller MM; Breuhahn K; Schirmacher P; Benner A; Heiss C
    Int J Cancer; 2012 Feb; 130(3):575-83. PubMed ID: 21400513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.
    Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
    BMC Cancer; 2013 Oct; 13():505. PubMed ID: 24165089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
    Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization.
    Sparano A; Quesnelle KM; Kumar MS; Wang Y; Sylvester AJ; Feldman M; Sewell DA; Weinstein GS; Brose MS
    Laryngoscope; 2006 May; 116(5):735-41. PubMed ID: 16652080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.